Evaluation of the use of Cannabidiol in Third Molar Extractio

Phase 1

• Conditions: Pain Management; Inflammation; A14.549.167.860.525.500

• Registration Number: RBR-8rv93wn
• Lead Sponsor: niversidade Federal de Uberlândia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-10-17
• Last Update Posted: 23 January 2024
• Study Completion: 2025-12-10

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients of both genders. aged between 18 and 60 years. who are systemically healthy and who require surgery to remove the four third molars

Exclusion Criteria

Patients using drugs acting on the central nervous system. decompensated diabetics (glycated hemoglobin above 8%). consumption of any medication 15 days prior to inclusion in this study, patients with hypersensitivity to the drugs to be used in postoperative care, pregnant women or during lactation. chronic smokers and alcoholics. presence of periapical lesions. presence of pericoronitis lesions

Study & Design

• Study Type: Intervention
• Study Design: Not specified